Hence, we examined the hypothesis that IL-33 contributes to obesity-related increases in the response to O3. To do so, we treated lean wildtype (WT) and obese db/db mice with an ST2 blocking or isotype antibody prior to O3 exposure. Here, IL33 is linked to obesity disorder.